Deguelin, an Akt inhibitor, down-regulates NF-κB signaling and induces apoptosis in colon cancer cells and inhibits tumor growth in mice.

MLA

Kang HW, et al. “Deguelin, an Akt Inhibitor, down-Regulates NF-ΚB Signaling and Induces Apoptosis in Colon Cancer Cells and Inhibits Tumor Growth in Mice.” Digestive Diseases & Sciences, vol. 57, no. 11, Nov. 2012, pp. 2873–82. EBSCOhost, https://doi.org/10.1007/s10620-012-2237-x.

APA

Kang HW, Kim JM, Cha MY, Jung HC, Song IS, Kim JS, Kang, H. W., Kim, J. M., Cha, M. Y., Jung, H. C., Song, I. S., & Kim, J. S. (2012). Deguelin, an Akt inhibitor, down-regulates NF-κB signaling and induces apoptosis in colon cancer cells and inhibits tumor growth in mice. Digestive Diseases & Sciences, 57(11), 2873–2882. https://doi.org/10.1007/s10620-012-2237-x

Chicago

Kang HW, Kim JM, Cha MY, Jung HC, Song IS, Kim JS, Hyoun Woo Kang, et al. 2012. “Deguelin, an Akt Inhibitor, down-Regulates NF-ΚB Signaling and Induces Apoptosis in Colon Cancer Cells and Inhibits Tumor Growth in Mice.” Digestive Diseases & Sciences 57 (11): 2873–82. doi:10.1007/s10620-012-2237-x.